BLOODPAC’s Executive Director, Lauren Leiman, will participate in a panel discussion at the inaugural Canaccord Genuity Early Cancer Detection Day 2026 on Tuesday, March 24, 2026. She will join the session, “Product Launch is Just the Start – How to Navigate the Hurdles to Broader Adoption of Next-Generation Screening.”

Lauren will be joined by fellow panelists Allen Chen and David Harding, with moderation by Kyle Mikson.

This is a virtual event. You can access the event website here.